CNO (CNO) Up 6.6% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2280746/cno-cno-up-6-6-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2280746
May 29, 2024 - CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Why Is Arch Capital (ACGL) Up 9.3% Since Last Earnings Report?
https://www.zacks.com/stock/news/2280750/why-is-arch-capital-acgl-up-9-3-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2280750
May 29, 2024 - Arch Capital (ACGL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
https://www.zacks.com/stock/news/2280718/prothena-prta-bristol-myers-tie-up-for-second-neuro-candidate?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2280718
May 29, 2024 - Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.
0
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
https://www.fool.com/investing/2024/05/29/astrazeneca-just-massively-one-upped-pfizer-heres/?source=iedfolrf0000001
May 29, 2024 - Both businesses have road maps for the future, but one is better.
0
Hormel Foods (HRL) Gears Up for Q2 Earnings: Is a Beat Likely?
https://www.zacks.com/stock/news/2280519/hormel-foods-hrl-gears-up-for-q2-earnings-is-a-beat-likely?cid=CS-ZC-FT-analyst_blog|earnings_preview-2280519
May 29, 2024 - Hormel Foods' (HRL) second-quarter results are likely to reflect gains from strategic priorities and strength in the Foodservice business, while advertising costs are expected to escalate.
0
AEON Biopharma Cuts 55% Of Workforce, Terminates CFO To Preserve Cash; Stock Up In Pre-market
https://www.rttnews.com/story.aspx?Id=3450910
May 29, 2024 - AEON Biopharma, Inc. (AEON) announced Wednesday a workforce reduction by approximately 55% as part of its strategic reprioritization and cost reduction plan. The company has terminated Peter Reynolds as the chief financial officer, principal financial officer and principal accounting officer, effective as of May 17, under its cash preservation strategy.
0
Roth conversions are up in 2024 — but it's not always a 'slam dunk,' accountant says
https://www.cnbc.com/2024/05/28/roth-conversion-right-for-your-portfolio.html
May 29, 2024 - There's an uptick in Roth conversions in 2024, according to Fidelity Investments. Here's how to know if the strategy is right for your portfolio.
0
Affimed's AFM24 With Atezolizumab For EGFR Wild-Type NSCLC Gets FDA Fast Track Status; Stock Up
https://www.rttnews.com/story.aspx?Id=3450812
May 29, 2024 - Affimed N.V. (AFMD), a clinical-stage immuno-oncology company, Wednesday announced that it has received Fast Track Designation from the U.S. Food and Drug Administration for combination therapy of AFM24 with Atezolizumab for EGFR Wild-Type non-small cell lung cancer or NSCLC.
0
Don't Just Bank on Social Security. Here's How to Set Yourself Up for a Millionaire Retirement.
https://www.fool.com/retirement/2024/05/29/dont-just-bank-on-social-security-heres-how-to-set/?source=iedfolrf0000001
May 29, 2024 - Retiring on those benefits alone could prove disastrous.
0
Box Q1 FY25 Earnings: All Boxed Up And Nowhere To Go
https://seekingalpha.com/article/4696127-box-q1-earnings-outlook-clouded-inconsistent-performance-lack-double-digit-growth?source=feed_all_articles
May 28, 2024 - Box, Inc.'s profitability metrics showed stronger signs of growth. Click here to see why BOX stock is a Hold.
0